Myriad Genetics (MYGN) Free Cash Flow Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -117.95% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 126.04% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 2.94% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 24.06% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 87.85% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 15.26% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -20.33% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 20.67% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -30.93% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | 2.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.31% |
| Dec 31, 2025 | 96.67% |
| Sep 30, 2025 | 753.57% |
| Jun 30, 2025 | -530.77% |
| Mar 31, 2025 | 14.62% |
| Dec 31, 2024 | 102.70% |
| Sep 30, 2024 | -120.59% |
| Jun 30, 2024 | 86.80% |
| Mar 31, 2024 | 55.38% |
| Dec 31, 2023 | -111.60% |
| Sep 30, 2023 | 33.33% |
| Jun 30, 2023 | 65.07% |
| Mar 31, 2023 | -7.39% |
| Dec 31, 2022 | -307.75% |
| Sep 30, 2022 | 124.11% |
| Jun 30, 2022 | -533.71% |
| Mar 31, 2022 | -181.61% |
| Dec 31, 2021 | 84.19% |
| Sep 30, 2021 | 30.43% |
| Jun 30, 2021 | -121.45% |